Cargando…
Pretreatment of leukemic cells with low-dose decitabine markedly enhances the cytotoxicity of gemtuzumab ozogamicin
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3542629/ https://www.ncbi.nlm.nih.gov/pubmed/22814292 http://dx.doi.org/10.1038/leu.2012.178 |
| _version_ | 1782255549913497600 |
|---|---|
| author | Kurimoto, M Matsuoka, H Hanaoka, N Uneda, S Murayama, T Sonoki, T Nakakuma, H |
| author_facet | Kurimoto, M Matsuoka, H Hanaoka, N Uneda, S Murayama, T Sonoki, T Nakakuma, H |
| author_sort | Kurimoto, M |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-3542629 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2013 |
| publisher | Nature Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-35426292013-01-11 Pretreatment of leukemic cells with low-dose decitabine markedly enhances the cytotoxicity of gemtuzumab ozogamicin Kurimoto, M Matsuoka, H Hanaoka, N Uneda, S Murayama, T Sonoki, T Nakakuma, H Leukemia Letter to the Editor Nature Publishing Group 2013-01 2012-07-20 /pmc/articles/PMC3542629/ /pubmed/22814292 http://dx.doi.org/10.1038/leu.2012.178 Text en Copyright © 2013 Macmillan Publishers Limited http://creativecommons.org/licenses/by-nc-nd/3.0/ This work is licensed under the Creative Commons Attribution-NonCommercial-No Derivative Works 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ |
| spellingShingle | Letter to the Editor Kurimoto, M Matsuoka, H Hanaoka, N Uneda, S Murayama, T Sonoki, T Nakakuma, H Pretreatment of leukemic cells with low-dose decitabine markedly enhances the cytotoxicity of gemtuzumab ozogamicin |
| title | Pretreatment of leukemic cells with low-dose decitabine markedly enhances the cytotoxicity of gemtuzumab ozogamicin |
| title_full | Pretreatment of leukemic cells with low-dose decitabine markedly enhances the cytotoxicity of gemtuzumab ozogamicin |
| title_fullStr | Pretreatment of leukemic cells with low-dose decitabine markedly enhances the cytotoxicity of gemtuzumab ozogamicin |
| title_full_unstemmed | Pretreatment of leukemic cells with low-dose decitabine markedly enhances the cytotoxicity of gemtuzumab ozogamicin |
| title_short | Pretreatment of leukemic cells with low-dose decitabine markedly enhances the cytotoxicity of gemtuzumab ozogamicin |
| title_sort | pretreatment of leukemic cells with low-dose decitabine markedly enhances the cytotoxicity of gemtuzumab ozogamicin |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3542629/ https://www.ncbi.nlm.nih.gov/pubmed/22814292 http://dx.doi.org/10.1038/leu.2012.178 |
| work_keys_str_mv | AT kurimotom pretreatmentofleukemiccellswithlowdosedecitabinemarkedlyenhancesthecytotoxicityofgemtuzumabozogamicin AT matsuokah pretreatmentofleukemiccellswithlowdosedecitabinemarkedlyenhancesthecytotoxicityofgemtuzumabozogamicin AT hanaokan pretreatmentofleukemiccellswithlowdosedecitabinemarkedlyenhancesthecytotoxicityofgemtuzumabozogamicin AT unedas pretreatmentofleukemiccellswithlowdosedecitabinemarkedlyenhancesthecytotoxicityofgemtuzumabozogamicin AT murayamat pretreatmentofleukemiccellswithlowdosedecitabinemarkedlyenhancesthecytotoxicityofgemtuzumabozogamicin AT sonokit pretreatmentofleukemiccellswithlowdosedecitabinemarkedlyenhancesthecytotoxicityofgemtuzumabozogamicin AT nakakumah pretreatmentofleukemiccellswithlowdosedecitabinemarkedlyenhancesthecytotoxicityofgemtuzumabozogamicin |